EP Patent

EP0109281A1 — Compositions comprising flurbiprofen or ibuprofen

Assigned to Pharmacia and Upjohn Co · Expires 1984-05-23 · 42y expired

What this patent protects

Pharmaceutical compositions comprise, as a first active ingredient, flurbiprofen or ibuprofen (or an ester or salt thereof), acetaminophen as a second active ingredient, and a carrier, for combined administration. For concomitant administration, a package includes separate compos…

USPTO Abstract

Pharmaceutical compositions comprise, as a first active ingredient, flurbiprofen or ibuprofen (or an ester or salt thereof), acetaminophen as a second active ingredient, and a carrier, for combined administration. For concomitant administration, a package includes separate compositions respectively comprising the first and second active ingredients. Use of such compositions, for combined or concomitant administration of the first and second active compounds, allows a reduction in the normal therapeutic dosage of acetaminophen.

Drugs covered by this patent

Patent Metadata

Patent number
EP0109281A1
Jurisdiction
EP
Classification
—
Expires
1984-05-23
Drug substance claim
No
Drug product claim
No
Assignee
Pharmacia and Upjohn Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.